Protocol for Sub-Study of the ASCOT Trial

Ethnic variations in response to a statin (EVIREST)

• NR Poulter
• M Caulfield
• G Feder

Microvolt T wave alternans in patients with hypertension and left ventricular hypertrophy

• D Francis
• R Lane
• NS Peters

Baroreflex sensitivity and heart rate variability as predictors of cardiovascular outcome in hypertensive patients with multiple risk factors for coronary disease

• DJ Collier
• L Bernardi
• P Sleight

Comparative effects of atenolol-based and amlodipine-based antihypertensive therapy on QT dispersion in hypertensive subjects

• L Oikarinen
• M Viitasalo
• MS Nieminen

Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo

• MS Nieminen
• J Viikari
• H Vanhanen

Microalbuminuria in type 2 diabetic hypertensive patients in ASCOT

• JP O’Hare

The suitability of an automated blood pressure measuring device—the Omron HEM-705CP—in a large multicentre study: the ASCOT study

• H O’Neill
• E O’Brien
• K Hedditch

The effects of cardiac events on quality of life and indirect costs

• B Jönsson
• M Buxton
• P Svarvar

Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

• B Jönsson
• M Buxton
• N Poulter

Left ventricular hypertrophy and silent ischaemia: a pilot study to examine the relationship in hypertensive patients

• E O’Brien
• C Gribbin
• S Lyons

Non-specific effects of inclusion in a clinical trial: information from ASCOT

• S Thom
• A Whitehouse
• N Poulter

Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life?

• R Horne
• J Clatworthy
• J Weinman

Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment

• CGC Spencer
• DG Beevers
• GYH Lip

Health-related quality of life and psychological factors in treatment of hypertension

• J Julkunen

Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients

• E O’Brien
• GT McInnes
• FM Nichol

Differential response to amlodipine and atenolol mono-therapy for hypertension by ethnic group

• PL Kirby
• MC Caulfield
• GS Feder

Cardiovascular risk factors in a cohort of 30 000 high-risk men and women in the UK: cross-sectional, retrospective and prospective studies of screenees for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

• JN Chapman
• P Kirby
• NR Poulter

Evaluation of cardiovascular risk equations using the ASCOT cohort

• S Wilson
• D Collier
• M Caulfield

The Conduit Artery Functional Endpoint (CAFE) study in ASCOT

• B Williams
• M O’Rourke

Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics

• P Uusimaa
• H Tokola
• K Peuhkurinen